TS-143

· Taisho Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TS-143, covering 2025-02-28 to 2025-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration) [Phase 1]